A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis

  • Daphne N. Weemering
  • , Mark Midei
  • , Peter Milner
  • , Vidhya Gopalakrishnan
  • , Anil Kumar
  • , Andrew J. Dannenberg
  • , Tommy M. Bunte
  • , Juliette Foucher
  • , Caroline Ingre
  • , Viktorija Ķēniņa
  • , Karin Rallmann
  • , Leonard H. van den Berg
  • , Ruben P.A. van Eijk (Corresponding Author)

Research output: Contribution to journal › Article › peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science